Bristol Myers (BMY) Squibb announced the final analysis of overall survival, or OS, from the Phase 3 CheckMate -816 study, which evaluated Opdivo, or nivolumab, in combination with platinum ...
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. A newly discovered welcome screen design for Chrome OS contains clues that Google is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback